Back to mobile site

Barclays Starts Cincor Pharma Inc (CINC) at Overweight

December 7, 2022 5:53 AM EST Send to a Friend
Barclays analyst Leon Wang initiates coverage on Cincor Pharma Inc (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login